[1]
A. . Esmail, Y. . Rayyan, H. . Rayyan, and M. . Abdelrahim, “Evaluating Standardization of Neoadjuvant Immunotherapy in Transplant-Eligible Hepatocellular Carcinoma Populations”, Jordan Med. J., vol. 59, no. 1, Feb. 2025.